Searched for
PDUFA
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...- US FDA fires most negotiators for pharma user fee talks, sources sayMass layoffs at the FDA, including senior negotiators, have disrupted the process of reauthorizing user fee programs that fund the agency's...
- Glenmark's NDA gets US FDA nodDrug firm Glenmark on Wednesday said US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for pain killer oxyc...
- Load More